Despite the completion of several multi-center clinical trials comparing me
dical management and carotid endarterectomy, there is still controversy as
to when carotid endarterectomy is appropriate. The volume of this surgery a
ppears to be increasing. However, available performance data indicate that
the surgical proficiency required for the clinical trials is not achieved u
niformly in actual practice. Therefore, benefits of carotid endarterectomy,
when considered from a public health perspective, are limited by the follo
wing: (1) endarterectomy is an expensive stroke prevention modality; (2) en
darterectomy addresses the needs of only a relatively small subset of strok
e patients, and (3) endarterectomy for asymptomatic patients, without clear
er evidence that these individuals benefit, may decrease the cost-effective
ness of this surgical procedure.